The OS and DFS of OSCC patients with high TSPEAR-AS2 expression were distinctly shorter than those with low TSPEAR-AS2 expression, which was consistent with the prognostic value of TSPEAR-AS2 expression in gastric cancer patients [17]. This evidence concerns the gene TSPEAR and gastric cancer.